Table 4.
Prediction of pharmacokinetic properties for HA, miltefosine, amphotericin B and curcumin using SwissADME.
| Compound | Molecular Weight | ESOL LogS | ESOL Class | GI Absorption | BBB Permeant | Pgp substrate | Bioavailability score | 
|---|---|---|---|---|---|---|---|
| HA | 316.4 | -5.25 | Moderately soluble | High | Yes | No | 0.56 | 
| Miltefosine | 407.6 | -5.32 | Moderately soluble | Low | No | Yes | 0.55 | 
| Amphotericin B | 924.1 | -5.37 | Moderately soluble | Low | No | Yes | 0.17 | 
| Curcumin | 368.4 | -3.94 | Moderately soluble | High | No | No | 0.55 | 
Properties determined include P-glycoprotein substrate (Pgp), Gastrointestinal absorption (GI), Blood Brain Barrier permeation (BBB), Estimated Solubility (ESOL), and Bioavailability score.